2001 Clinical Trials Data Policy 
Cannabis Law Report
JUNE 10, 2021
Marijuana policies in the United States have become more permissive, motivating research on demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use. Marijuana policies in the United States (U.S.) Introduction.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 24, 2021
At the same time, the outlook on cannabis research data is largely positive. Data collection. One coder then independently coded the entire dataset and entered the data into NVivo v12. This offers a more denotative approach to complement the data. Only one article appeared in the MJA in 2000 and again in 2001.
Cannabis Law Report
JUNE 4, 2021
Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Amanda Feilding, Countess of Wemyss and March is an English drug policy reformer, lobbyist and research coordinator. Andrew Yang.
Cannabis Law Report
OCTOBER 17, 2019
Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018. Cannabis has been legal for medical purposes in Canada since 2001, with several iterations of regulation and legislation shaping the industry over the years. billion in 2025, according to Grandview Research.
Expert insights. Personalized for you.
59 
Let's personalize your content